Navigation Links
Health Outcomes Data Essential to Biopharmaceutical Sales Process

CHAPEL HILL, N.C., July 23 /PRNewswire/ -- Sales executives agree that delivering health outcomes data is increasingly important in the biopharmaceutical sales process. Yet only 6 percent of district sales managers currently understand and often communicate this type of data to sales representatives.  

"DMs need knowledge of health outcomes, evidence based medicine and reimbursement," states an interviewed sales executive in "Trends and Future Directions for the High Performing District Sales Manager." Slightly more than half of companies are using laptop-based presentations to equip managers and reps to communicate health outcomes data to physicians.

"Trends and Future Directions for the High Performing District Sales Manager," a report derived from primary research conducted by Best Practices, LLC, identifies recent changes, new directions, and best practices for the current and future roles of district sales managers in driving superior sales productivity and growth.

Download a complimentary white paper at that includes selected best practices drawn from extensive primary research with 94 sales leaders from 46 different pharmaceutical and biotechnology companies across 24 different countries on six continents. Benchmark partners include Novartis, Roche, Abbott, GlaxoSmithKline, Bristol-Myers Squibb, sanofi-aventis, Merck, Takeda, Boehringer Ingelheim.

Key topics include:

  • Sales Force Growth & Reduction Drivers
  • Detailed Sales Model Changes
  • Physician Access Levels
  • Critical DM Activities & Trends in DM Responsibilities
  • Essential DM Management, Leadership & Competency Skills
  • Impact of Pharma Model Changes on DMs
  • Pharma Sales Rep Licensing
  • DM Readiness for Change

The full 73-page report contains more than 500 benchmark metrics and 47 executive narratives collected from two benchmarking studies conducted during the past three years, providing sales executives with longitudinal data about the shifts and developments of the roles and responsibilities of the influential DM.

For more information on this study or other recent primary research studies, contact us at 919.403.0251 or at  

BEST PRACTICES, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for more than 17 years; our clients include 48 out of the top 50 pharmaceutical companies.

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CRF Health is Awarded for Getting Closer
2. Bayer HealthCare Pharmaceuticals Supports New Jersey Governors School in the Sciences at Drew University
3. Amicus CEO Represents BIO on Rare Diseases at U.S. Senate Committee on Health, Education, Labor and Pensions Bipartisan Hearing
4. ID Experts Announces RADAR™: A HITECH Risk Assessment Tool for Healthcare Security Breach Incidents Affecting Patient Privacy
5. AstraZeneca and Grace Hill Neighborhood Health Centers, Inc. Provide Medicines to Missouris Uninsured
6. Zimmer Holdings to Present at BMO Capital Markets Tenth Annual Focus on Healthcare Conference
7. Health Robotics CytoCare Continues European Expansion With Grifols and Vall dHebron University Hospital
8. BIO Ventures for Global Health Opens San Francisco Office; Hires New Senior Staff
9. Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community
10. Hudson Valley Physician Testifies Before House Health Subcommittee Tuesday About Incentives for Adoption of Health Information Technology
11. MedWest Health System Selects Allscripts Electronic Health Record and Practice Management for Employed Physicians
Post Your Comments:
(Date:11/24/2015)... -- The uptake of recently approved and pipeline premium products ... market growth to 2021, says GBI Research . ... for Type 1 Diabetes Mellitus (T1DM), will be a key driver of ... --> The uptake of recently approved and pipeline premium ... of market growth to 2021, says GBI Research ...
(Date:11/24/2015)... 24, 2015   Renowned ... deliver s advice and insights on ... More than 50% of Dubai ... according to the DHA   femMED launches comprehensive solutions for ... Dubai residents are not consuming enough to keep ...
(Date:11/24/2015)...  Freudenberg Medical has developed specialty tubing for an inexpensive, ... facilities. Africa and ... Nevertheless, prompt diagnosis is important to treat those affected and ... the help of a portable mini-lab or "lab on a ... affected areas and perform rapid testing for HIV. They do ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... November 24, 2015 , ... ... their Black Friday sale a week early, offering 40% off select bras and ... intimate apparel industry through both mobile fit technology and the latest fashion, quickly ...
(Date:11/24/2015)... ... November 24, 2015 , ... DMG Productions announced that they will ... first quarter 2016 via Discovery Channel. Dates and show times TBA. , Aphria, Inc., ... in the business of producing and supplying medical marijuana pursuant to the Marijuana for ...
(Date:11/24/2015)... City, UT (PRWEB) , ... November 24, 2015 , ... ... Forbes Magazine. For a business, it is critical that the first impression be positive ... business, they are not likely to buy anything or want to return. They will ...
(Date:11/24/2015)... Richey, FL (PRWEB) , ... November 24, 2015 , ... ... deems a growing epidemic as deaths from prescription opioids in the United States grew ... and cocaine. In 2013 alone, opioids were involved in 37 percent of all fatal ...
(Date:11/24/2015)... ALEXANDRIA, VA (PRWEB) , ... November 24, 2015 ... ... encourages people across the United States to support their local poison centers through ... been designated as #GivingTuesday: calls it “a day that inspires people to ...
Breaking Medicine News(10 mins):